EVT-601

N/A

Report date: 2025/01/26 17:02:47

NME

Base Information

Drug NameEVT-601

Drug Alias Nameallosteric FGFR antagonist (Evotec)EVT-601

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionFibroblast growth factor receptor 2 antagonistsFibroblast growth factor receptor 3 antagonistsFibroblast growth factor receptor 4 antagonists +[4]

TargetsFibroblast growth factor receptor 4Fibroblast growth factor receptor 1Fibroblast growth factor receptor 3 +[4]

Therapy Area/IndicationsInflammationNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesEvotec SE

China Registration ClassN/A

Develop Information

Active CompaniesEvotec SE

Inactive CompaniesN/A

Active IndicationsInflammationNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A